Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

Core Insights - Eton Pharmaceuticals is set to participate in the Piper Sandler 37th Annual Healthcare Conference on December 4, 2025, at 9:30 AM ET in New York City [1] Company Overview - Eton Pharmaceuticals focuses on developing and commercializing treatments for rare diseases, currently offering eight commercial products [2] - The company's commercial rare disease products include KHINDIVI™, INCRELEX, ALKINDI SPRINKLE, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone [2] - Eton has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800, and ZENEO hydrocortisone autoinjector [2]